| Date | Time | Source | Headline | Symbol | Company |
| 09/24/2024 | 11:07AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 09/24/2024 | 6:10AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 09/19/2024 | 8:00AM | GlobeNewswire Inc. | Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024) | NYSE:GSK | GSK plc |
| 09/19/2024 | 6:26AM | IH Market News | AIG names new CFO; Progyny Drops 24% After Losing Key 2025 Contract; Exicure Jumps 190% With Nasdaq Extension | NYSE:GSK | GSK plc |
| 09/18/2024 | 7:00AM | Business Wire | GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX | NYSE:GSK | GSK plc |
| 09/16/2024 | 1:04PM | PR Newswire (US) | Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk | NYSE:GSK | GSK plc |
| 09/13/2024 | 6:29AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 09/12/2024 | 10:56AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 09/12/2024 | 6:34AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 09/11/2024 | 6:25AM | IH Market News | GameStop plunges 11% on stock offering, DJT drops post-debate, GSK fails shingles vaccine trial | NYSE:GSK | GSK plc |
| 09/06/2024 | 11:12AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 09/06/2024 | 6:14AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 09/03/2024 | 6:17AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 08/28/2024 | 5:50AM | IH Market News | High Volatility Expected in Nvidia Report, Ambarella Soars 20%, Hertz Strengthens Board, Apple Cuts Jobs | NYSE:GSK | GSK plc |
| 08/06/2024 | 4:05PM | GlobeNewswire Inc. | Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12% | NYSE:GSK | GSK plc |
| 08/01/2024 | 3:44PM | Business Wire | US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit | NYSE:GSK | GSK plc |
| 07/31/2024 | 12:28PM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 07/30/2024 | 6:03AM | IH Market News | F5 Shares Rise 15%; Diageo Falls 10% on Annual Sales Decline; BP Boosts Dividend and Buyback Program | NYSE:GSK | GSK plc |
| 07/29/2024 | 6:24AM | IH Market News | Apple Delays AI Features, Abbott Shares Plunge 7% After $495M Fine, Philips Soars 10% | NYSE:GSK | GSK plc |
| 07/29/2024 | 6:23AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 07/29/2024 | 6:16AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 07/19/2024 | 7:08AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 07/18/2024 | 11:53AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 07/16/2024 | 10:44AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 07/15/2024 | 1:14PM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 07/12/2024 | 11:15AM | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:GSK | GSK plc |
| 07/11/2024 | 8:00AM | Business Wire | GSK Begins Shipping Influenza Vaccine Doses for 2024-25 Season | NYSE:GSK | GSK plc |
| 07/03/2024 | 6:59AM | IH Market News | Apple Joins OpenAI Board, Logitech President Opts Out of Reelection, and More News | NYSE:GSK | GSK plc |
| 06/27/2024 | 7:13AM | IH Market News | Interactive Brokers Loses $48 Million on NYSE, Amazon Achieves Historic Market Value, and More News | NYSE:GSK | GSK plc |
| 06/07/2024 | 6:57PM | Business Wire | US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk | NYSE:GSK | GSK plc |